Literature DB >> 620203

Adrenocortical suppression in workers manufacturing synthetic glucocorticoids.

R W Newton, M C Browning, J Iqbal, N Piercy, D G Adamson.   

Abstract

A man who had worked for 16 years in the manufacture of a potent corticosteroid was found to be suffering from chronic adrenocortical insufficiency attributed to chronic absorption of the glucocorticoid. Eleven other symptom-free workers were therefore screened. Two of these workers, like the first patient, gave grossly abnormal responses to the Synacthen (tetracosactrin) test; one had been employed for only seven months. All 12 men had facial plethora, suggesting absorption of the drug in spite of their having adhered to the safety precautions. All workers manufacturing potent steroids should therfore be screened regularly by measurement of their plasma cortisol concentrations and should be moved regularly to processing other drugs.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 620203      PMCID: PMC1602646          DOI: 10.1136/bmj.1.6105.73

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  6 in total

1.  Recovery of adrenocortical function during long-term treatment with corticosteroids.

Authors:  L Westerhof; M J van Ditmars; J H Thijssen; F Schwarz
Journal:  Br Med J       Date:  1970-11-28

2.  Adrenal cortical function in children on steroids.

Authors:  J A Kuzemko; J G Lines
Journal:  Arch Dis Child       Date:  1970-04       Impact factor: 3.791

3.  Criteria for distinguishing normal from subnormal adrenocortical function using the Synacthen test.

Authors:  W R Greig; J D Maxwell; J A Boyle; R M Lindsay; M C Browning
Journal:  Postgrad Med J       Date:  1969-05       Impact factor: 2.401

4.  Inhibition by dexamethasone of the in vivo pituitary response to corticotropin-releasing factor (CRF).

Authors:  S M Russell; A P Dhariwal; S M McCann; F E Yates
Journal:  Endocrinology       Date:  1969-09       Impact factor: 4.736

5.  Plasma "cortisol" response to Synacthen in patients on long-term small-dose prednisone therapy.

Authors:  J A Hicklin; M R Wills
Journal:  Ann Rheum Dis       Date:  1968-01       Impact factor: 19.103

6.  Effect of dinitrophenol on pituitary-thyroid activity in the rat.

Authors:  J L Bakke; N Lawrence
Journal:  Endocrinology       Date:  1965-08       Impact factor: 4.736

  6 in total
  4 in total

1.  Exposure to quinalbarbitone sodium in pharmaceutical workers.

Authors:  P J Baxter; A M Samuel; T C Aw; J Cocker
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-08

2.  Adrenocortical suppression in workers employed in manufacturing synthetic glucocorticosteroids: solutions to a problem.

Authors:  R W Newton; M C Browning; P C Nicholson; D A Mowat
Journal:  Br J Ind Med       Date:  1982-05

3.  Determination of Glucocorticoids in UPLC-MS in Environmental Samples from an Occupational Setting.

Authors:  Enrico Oddone; Sara Negri; Massimo Bellinzona; Silvia Martino; Marcello Di Tuccio; Elena Grignani; Danilo Cottica; Marcello Imbriani
Journal:  Int J Anal Chem       Date:  2015-03-03       Impact factor: 1.885

4.  THE ORGANOTROPIC, BACTERIOTROPIC, AND LEUCOCYTOTROPIC ACTIONS OF CERTAIN ORGANIC CHEMICALS.

Authors:  L D Felton; K M Dougherty
Journal:  J Exp Med       Date:  1922-07-31       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.